Belite Bio to Host Webcast on May 20, 2026, to Discuss First Quarter 2026 Financial Results
Stocks in this Quantisnow insightHealth Care
Historical context for BLTE
Across the 17 sessions after earlier BLTE headlines, the stock closed higher 12 times and lower 5 times, with a median move of 3.7% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | BLTE | SPY |
|---|---|---|---|
| Apr 27, 2026 | Belite Bio Announces Oral Presentation at the Retinal Therapeutics Innovation Summit | +1.1% | +0.2% |
| Apr 23, 2026 | Belite Bio to Participate in Four Upcoming Investor Conferences | -1.8% | -0.4% |
| Apr 22, 2026 | Belite Bio to Present at the Deutsche Bank American Depositary Receipt Virtual Investor Conference on April 28thand 1 other headline that session | +1.3% | +1.0% |
| Mar 31, 2026 | Belite Bio Announces Availability of Annual Report on Form 20-F Through Company Website | +6.9% | +2.9% |
| Mar 2, 2026 | Belite Bio to Participate in the Leerink Global Healthcare Conferenceand 1 other headline that session | -6.7% | +0.1% |
| Feb 23, 2026 | Belite Bio to Host Webcast on March 2, 2026, to Discuss Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Results | +4.6% | -1.0% |
Quantisnow market dataNASDAQ
BLTE
Belite Bio Inc
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2022
Get push alerts for BLTE
Full BLTE profile on Quantisnow Follow BLTE and get a push notification the moment its next story breaks.